Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions
Hormonal Contraception and Treatment of Depression
JAMA Psychiatry; 2016 Nov 1; Skovlund, et al
The use of hormonal contraception was associated with subsequent use of antidepressants and a first diagnosis of depression, especially among adolescents, a recent study found. This cohort included 1,061,997 women and adolescents aged 15 to 34 years and followed up from January 1, 2000, to December 2013 if they had no prior depression diagnosis, redeemed prescription for antidepressants, other major psychiatric diagnosis, cancer, venous thrombosis, or infertility treatment. Researchers found:
• Users of combined oral contraceptives had a relative risk (RR) of first use of an antidepressant of 1.23.
• Users of progestogen-only pills had an RR for first use of an antidepressant of 1.34; patch users, 2.0; users of a vaginal ring, 1.6; and users of a levonorgestrel intrauterine system, 1.4.
• Similar or slightly lower estimates were observed for depression diagnoses.
• Adolescents (aged 15 to 19 years) using combined oral contraceptives had an RR of a first use of an antidepressant of 1.8 and those using progestin-only pills, 2.2.
• RR of antidepressant use peaked at 1.4, 6 months after starting use of hormonal contraceptives.
Citation: Skovlund CW, Mørch LS, Kessing LV, Lidegaard Ø. Association of hormonal contraception with depression. JAMA Psychiatry. 2016;73(11):1154-1162. doi:10.1001/jamapsychiatry.2016.2387.
1. Klein JD, et al. Adolescent pregnancy: Current trends and issues. Pediatrics. 2005;116:281–286. doi:10.1542/peds.2005-0999.